Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,067 total articles
Impala Platinum is trading like a producer that has already priced in both higher PGM prices and persistent South African operational risk. With production growth stalled, the next move in the stock will be driven by metal prices and geopolitical/labor headlines. This is a tactical long: enter on strength or on a shallow pullback, tight stop to pro…
Nvidia's recent pullback has pushed the stock back toward $190 despite record free cash flow, an $4.76 trillion market cap and industry-leading returns on capital. Fundamentals remain intact and technicals show oversold-but-not-broken conditions. I recommend a mid-term long with an entry at $192.00, stop at $177.00 and target at $230.00 (45 trading…
e.l.f. Beauty has leaned into targeted price markdowns and Rhode-led assortment expansion to reignite top-line momentum. Recent tests show sharp volume uplift after cuts, technicals favor continuation, and valuation looks reasonable relative to forward earnings assumptions. This trade idea outlines a mid-term long with clear entry, stop and target …
FactSet is trading well below its recent highs after a sharp re-rating, yet the underlying economics remain intact: $683M in free cash flow, ROE ~27.6%, and a sub-11x EV/EBITDA multiple. A limited release of Portfolio Analytics MCP and an upcoming earnings print create catalysts. This trade plan targets >30% upside in a 180-trading-day horizon with…
AeroVironment surged after a blowout quarter, but the pullback from recent highs leaves a cleaner risk/reward. Q4 revenue of ~$642M, funded backlog of $1.2B and FY27 guidance of $2.13B-$2.23B underpin a mid-term swing trade. Valuation is rich on some metrics but balance sheet and order visibility limit downside for disciplined buyers.
Netflix (NFLX) is a buy on a disciplined pullback. The company’s improving monetization mix, steady subscriber dynamics, and cash-flow conversion make it a lower-risk trade with meaningful upside over the next 180 trading days. Entry, stop, and target provided with clear risk controls.
Huntington (HBAN) looks constructive after a pullback earlier this year. The bank offers a 3.4% yield, a P/B near 1.1, and improving technical momentum. This is a mid-term swing trade: enter at $17.90, target $19.45, stop $16.50, horizon ~45 trading days.
Intuitive Machines just picked up another NASA engagement. The award itself is modest, but it validates the company’s role in cislunar infrastructure and supports a ratings upgrade. The balance sheet shows runway after a $500M capital raise, revenue momentum (record Q1 revenue $186.7M) and a $1.1B backlog. Valuation is elevated (market cap roughly …
Lockheed Martin (LMT) looks like a compelling entry after recent weakness. The company’s FCF generation ($5.66B) and durable backlog tied to the F-35 and missile defense programs support a constructive upgrade. Valuation at ~25x earnings and an enterprise value near $139B leaves room for total returns from dividends, buybacks and steady contract ex…
Honda (HMC) combines a >4% yield, a sub-1x PB multiple, and several near-term technology and policy catalysts that can re-rate the stock. The trade is a directional long sized for a swing horizon to capture reassessment of Honda's EV and hybrid strategy plus government-backed progress on solid-state batteries.
Sandisk sits at the center of the AI memory supercycle. With free cash flow of $4.46B, ROE above 32%, and tightly bid NAND markets, the company can sustain high profitability even as the stock trades at elevated multiples. This trade idea outlines a mid-duration long with specific entry, stop and target, plus the catalysts and risks that will matte…
Bloom Energy sits at the intersection of scalable on-site power and exploding AI compute demand. With a roughly $20 billion backlog, growing service revenue and multi-year deals with hyperscalers, the company has the growth profile to justify an aggressive long position. The stock is richly valued today, so this trade pairs conviction with a discip…
Palantir's stock has been punished in 2026 despite accelerating revenue and cash flow. With recent strategic deals (Nvidia, Army NGC2, Zeta Global), a slimmer short book and liquidity still ample, this is a high-risk, high-reward long idea: enter at $130.00, stop at $105.00, target $260.00 over a long-term (180 trading days) horizon.
Alcoa (AA) has retraced hard from its 52-week high and now trades at attractive multiples relative to earnings and enterprise value. With EPS near $3.92, EV/EBITDA roughly 8.6x, modest leverage, and an improving aluminum supply story, this looks like a tactical long. The trade plan targets a rebound to $62 with a protective stop at $44 over a mid-t…
CoreWeave sits at the center of specialized GPU infrastructure demand with an unusually large backlog and a valuation that, on a qualitative basis, looks cheaper than peers. This trade targets a re-rate as backlog converts to revenue, while protecting capital with a defined stop and realistic target over a 180-trading-day horizon.
Galderma (GALDY) looks like a buy after price action and sector data point to multi-engine growth acceleration: aesthetics, prescription dermatology and self-care are all showing secular strength. Technical momentum, L'Oréal's increased stake and outsized short activity create a favorable risk/reward for a disciplined long trade. Entry $44.00, stop…
CoreWeave (CRWV) sold off sharply after news that Meta will monetize excess AI compute. That knee-jerk reaction overstates the short-term competitive threat and ignores CoreWeave's position as a GPU-optimized, third-party compute provider with differentiated customers and momentum. This trade recommends a long-term buy at current levels with a $120…
B2Gold looks set to deliver a lift in free cash flow if planned production ramps and cost targets hold. This trade idea buys that narrative while protecting capital against operational, geopolitical and gold-price risks. Entry $4.80, stop $3.90, target $7.20 - mid-term initial hold with a long-term follow-through if catalysts land.
NetApp's recent results and partnerships show enterprise AI is not just an upside scenario - it's changing the company's revenue mix and margin profile. We lay out an actionable long trade with entry, stop, and target, and explain why AI-driven demand for managed data, cloud-native storage, and high-performance backup appliances justify a re-rating…
BSRTF is trading at $11.72 with neutral technicals, elevated short interest and daily short-volume spikes. This trade is a tactical, conditional long: if Texas markets normalize supply and capital flows return to REITs, small OTC names that have exposure stand to re-rate. Enter at current levels, limit risk with a tight stop and plan for a mid-term…
Energy Transfer (ET) trades like a high-yield utility with an embedded growth kicker from export capacity expansion. At $19.15, the partnership yields ~7% and sits on an enterprise base that generates $3.6B in free cash flow; EV/EBITDA is ~8.5x. For income investors who can stomach leverage, a measured long trade captures near-term rerating and lon…
NetApp posted strong Q4 results and a blowout rally in late May. The bull case now depends on whether NetApp can convert demand for AI and cloud storage into sustained market-share gains. This trade idea targets $185 with a tight stop to protect against reversion if channel momentum stalls.
Circle's share price has been hammered in 2026, yet fundamentals — scale of USDC, growing free cash flow, and institutional demand — plus pending regulatory moves make a mid-term long trade attractive. Entry at the current level, a conservative stop below $55, and a $90 target balance upside from clarity with an acceptable risk budget.
Solid Biosciences (SLDB) is trading at roughly $10.42 with a market cap near $1.0B but carries unusually strong balance-sheet metrics for a clinical-stage biotech. Recent regulatory designations, licensing deals around its next-gen AAV capsid, and pipeline diversification beyond Duchenne muscular dystrophy (DMD) create multiple near-term value cata…
Bandwidth is turning its cloud-communications platform into an AI growth story. With improving free cash flow ($79.4M), expanding enterprise uptake, and a market cap of roughly $2.04B, the risk/reward favors a disciplined long exposure. This trade idea lays out entry, stops, targets, catalysts and the key risks.
